A recombinant protein represents a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule comprises a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is mostly used in the development of novel therapies for chronic and rare diseases. It finds extensive applications in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.
How Big Is The Recombinant Protein Market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 170.9 Billion |
| Market Forecast in 2028 | US$ 279.7 Billion |
| Growth rate (2023 to 2028) | CAGR of 11.4% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
Global Recombinant Protein Market Trends:
The growing prevalence of several chronic diseases and the escalating demand for novel treatment options are among the key factors driving the recombinant protein market. Moreover, the increasing investments in the field of protein engineering and the inflating focus on the launch of protein-based drugs are also stimulating the market growth. Besides this, government bodies are funding research and development (R&D) activities to introduce advanced techniques in proteomics and genomics, which is acting as another significant growth-inducing factor. Furthermore, the introduction of high-quality autoantigens that are widely used in immunotherapy procedures, on account of the launch of recombinant protein expression technology, is further propelling the global market. Apart from this, the rising requirement for modified proteins for accurate measurement of biomarkers in the field of drug discovery is positively influencing the market growth. Additionally, the increasing penetration of the latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is anticipated to fuel the recombinant protein market over the forecast period.
Request For A Free Sample Copy Of This Report: https://www.imarcgroup.com/recombinant-protein-market/requestsample
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
Also Read :
Gaucher Disease Market Size to Reach US$ 2.35 Billion by 2028
Digital Pcr Market Size to Reach US$ 7.9 Billion by 2028
Dialysis Market Size to Reach US$ 148.8 Billion by 2028
Ambulatory Blood Pressure Monitoring Devices Market Size to Reach US$ 212.8 Million by 2028
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA USA: +1-631-791-1145 | Asia: +91-120-433-0800 Email: sales@imarcgroup.com Follow us on Twitter: @imarcglobal LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
Tags:
IPS, Extended Distribution, iCN Internal Distribution, Research Newswire, English